CompletedNCT03251716
Berberine for Metabolic Health in Women With Schizophrenia
About this title
Read the official source — NCT03251716Medication studyAges 18–60China
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- TianjinSee all locations and recruitment
Study information
Study start dateStarted: January 1, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 36
- Sponsor
- Tianjin Anding Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT03251716
- Official title
Show the full official title
Berberine in the Treatment of Metabolic Syndrome : an Open Label Clinical Study in Female Schizophrenia Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tianjin
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tianjin Anding Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including berberine.
Who was this study for?
Listed age limits: 18 years to 60 years.
